These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 371236)
21. [Administration of metopirone in the treatment of vitiligo]. Dolecek R Cas Lek Cesk; 1968; 107(38):1183-5. PubMed ID: 5682345 [No Abstract] [Full Text] [Related]
22. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355 [TBL] [Abstract][Full Text] [Related]
24. [Clinical and morphological study of the skin in patients with vitiligo during treatment with psoralen]. Arutiunov VIa; Arkhangel'skaia NV; Uzhvieva NV Vestn Dermatol Venerol; 1972 Feb; 46(2):8-12. PubMed ID: 5036805 [No Abstract] [Full Text] [Related]
25. [Vitiligo: its treatment with hypericin]. Fujii HM; Pedroza AR; González W Prensa Med Argent; 1966 Aug; 53(33):1812-7. PubMed ID: 5994110 [No Abstract] [Full Text] [Related]
26. [A new treatment for vitiligo: topical Kandil therapy combined with oral P.A.B.A]. Pozo Carballido JL Actas Dermosifiliogr; 1978; 69(11-12):369-74. PubMed ID: 380273 [No Abstract] [Full Text] [Related]
27. Calcipotriol in the treatment of childhood vitiligo. Gargoom AM; Duweb GA; Elzorghany AH; Benghazil M; Bugrein OO Int J Clin Pharmacol Res; 2004; 24(1):11-4. PubMed ID: 15575172 [TBL] [Abstract][Full Text] [Related]
28. Calcipotriene and corticosteroid combination therapy for vitiligo. Travis LB; Silverberg NB Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800 [TBL] [Abstract][Full Text] [Related]
29. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia]. Braĭtsev AV Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363 [No Abstract] [Full Text] [Related]
30. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease]. Yang RM Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875 [No Abstract] [Full Text] [Related]
31. [Clinical trial of psoberan in vitiligo]. Mirakhmedov UM; Abidov MM Vestn Dermatol Venerol; 1976 Feb; (2):77-9. PubMed ID: 936777 [No Abstract] [Full Text] [Related]
32. [Clinical effectiveness and the incidence of complications of the photochemotherapy of chronic dermatosis patients]. Skripkin IuK; Udzhukhu VIu; Korotkiĭ ; Kubanova AA; Magaryshkina OV Vestn Dermatol Venerol; 1983 Feb; (2):8-11. PubMed ID: 6845878 [No Abstract] [Full Text] [Related]
33. [Metyrapone in the therapy of vitiligo]. Dolecek R Cas Lek Cesk; 1983 May; 122(18):564-7. PubMed ID: 6850733 [No Abstract] [Full Text] [Related]
34. High-potency steroid use in children with vitiligo: a retrospective study. Kwinter J; Pelletier J; Khambalia A; Pope E J Am Acad Dermatol; 2007 Feb; 56(2):236-41. PubMed ID: 17224367 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of acute and chronic urinary tract infections in children with an urinary chemotherapeutic agent]. Chrapowicki T; Krzyzanowska-Rogozińska T; Kurowska D Z Allgemeinmed; 1975 Sep; 51(27):1215-9. PubMed ID: 1105992 [No Abstract] [Full Text] [Related]
40. Oral zinc sulphate treatment of chronic non-sickle cell ulcers in Jamaica. Gueri M; Van Devanter S; Serjeant BE; Serjeant GR West Indian Med J; 1975 Mar; 24(1):26-9. PubMed ID: 1094731 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]